News Article

Disc Brake Trial Restarts January 1 2017


BERN, Switzerland – The World Federation of the Sporting Goods Industry (WFSGI) as the representative body of the bicycle industry announced today that the trial of disc brakes in road racing will be restarted as of January 1, 2017.

Disc Brake Trial Restarts January 1 2017
Trial of disc brakes in road racing will be restarted as of January 1, 2017. - Photo Bike Europe

The UCI Management Commission has approved the restart during its meeting on October 13, 2016 at the occasion of the UCI Road World Championships in Doha, Qatar. The Commission has acknowledged the proposal of the UCI Equipment Commission that suggested to restart the trial only ten days ago.

Risk assessment

The decision comes after months of discussions by the UCI with representatives of teams through AIGCP (Association Internationale des Groupes Cyclistes Professionels), riders through CPA (Cyclistes Professionels Associés) and the industry represented by the WFSGI. The UCI which has also examined a risk assessment of disc and rim brakes with a third party institution, but also AIGCP and CPA finally supported the proposal to restart the trial of disc brakes.

Modified discs

The trial in 2017 will restart with the same team categories as in 2016, but will see a slight modification when it comes to the rotors of the disc brakes. Due to practical reasons which should guarantee a faster wheel exchange, the Commission decided to use discs which are modified to ensure the perimeter edge of the brake rotor does not contain any 90 degree edges but are smoothed or chamfered.


WFSGI Secretary General Robbert de Kock confirms the relieve within the bicycle industry: “The industry never doubted disc brakes to be a safe and well performing product. We appreciate that the good collaboration among AIGCP, CPA and UCI did help to get a better understanding on the circumstances around the introduction of this product and did finally lead to a positive decision. The WFSGI is also looking forward to working with the UCI and a working group on a periodical review of the trial period in 2017.”

Comment on this article